Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investors Research Corp lowered its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,177 shares of the biopharmaceutical company’s stock after selling 425 shares during the quarter. Investors Research Corp’s holdings […]
Choate Investment Advisors grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 10,052 shares of the biopharmaceutical company’s stock after acquiring an additional 358 shares during the period. Choate Investment Advisors’ holdings in […]
Adirondack Trust Co. lessened its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 16.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 2,230 shares of the biopharmaceutical company’s stock after selling 425 shares during the quarter. Adirondack Trust Co.’s holdings in Gilead Sciences were worth $167,000 at the end of […]
Exchange Capital Management Inc. increased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 9.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 37,740 shares of the biopharmaceutical company’s stock after purchasing an additional 3,346 shares during the quarter. Exchange Capital […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) insider Johanna Mercier sold 8,242 shares of the stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $85.23, for a total value of $702,465.66. Following the completion of the transaction, the insider now owns 82,729 shares in the company, […]